Explainer
Migraine explained: symptoms, triggers and the CGRP drugs
Migraine is a health condition that is more than a bad headache: attacks often bring throbbing one-sided pain, nausea and sensitivity to light and sound, and usually last 4 hours to 3 days.[1][2][3] Headache disorders affect about 40% of people worldwide, and migraine ranks third among neurological conditions for disease burden.[4] There is no cure, but acute medicines such as triptans, preventive medicines and, since 2018, drugs that block the pain-signalling protein CGRP can reduce attacks and symptoms.[5][6][7][8]
The WHO ranks migraine third among neurological conditions for disease burden.[4] Since 2018 a new class of medicines aimed at a migraine pain protein, CGRP, has joined older treatments.[7][8] This page explains what migraine is, how attacks unfold, when to seek urgent help and how treatment works.
This page is general information, not medical advice. It names medicine types but gives no doses. Talk to a doctor about diagnosis and treatment. Facts here come from the US National Institute of Neurological Disorders and Stroke (NINDS), the WHO and the NHS.
Get emergency help (999 in the UK, 911 in the US) for a sudden, extremely painful headache, or a headache with trouble speaking, vision loss, confusion, a seizure or weakness on one side.[9]
What migraine is
Migraine is more than a bad headache. Symptoms vary from person to person but often include headaches that keep coming back, nausea, vomiting, mood changes, tiredness and sensitivity to light, noise and smells.[1] A common symptom is moderate to severe throbbing pain, usually on one side of the head.[2] Attacks usually last between 4 hours and 3 days.[3]
Scientists think migraine pain happens when nerve signals, brain chemicals and blood vessels in the brain stop working properly. The exact cause is still unknown.[10]
NINDS summarises current research as showing that migraine pain arises from dysfunction of nerve signalling, brain chemistry and cerebral blood vessels. The WHO describes the exact cause as unknown, with the leading idea being release of pain-producing inflammatory substances around the nerves and blood vessels of the head.[10] A protein involved in migraine pain, calcitonin gene-related peptide (CGRP), rises during attacks and is the target of the newest drug class.[7]
Phases, types and triggers
An attack can unfold in phases.[11]
- Prodrome: the start of an episode, a few hours to a few days before the headache.
- Aura: only in some people, usually affecting vision, starting about 10 minutes to an hour before the headache and usually lasting no more than an hour.
- Headache.
- Postdrome: exhaustion or confusion that can last up to two days.
The most common type is migraine without aura. Chronic migraine means migraine headaches on at least 15 days a month for more than three months.[12]
Triggers differ between people. They include weather changes, too much or too little sleep, strong smells, stress, skipped meals, alcohol, hormonal changes, and bright or flashing lights.[13] Hormonal changes are probably why females have migraine more often than males, and most females improve after menopause.[14] People with migraine more often have depression, anxiety and sleep disorders.[15]
How common it is
The WHO estimates that headache disorders affected about 40% of the world’s population, 3.1 billion people, in 2021. They are more common in females.[4]
Diagnosis and warning signs
Doctors diagnose migraine from health history and physical and neurological exams. MRI or CT scans are not usually needed unless another cause is suspected. A headache journal can help.[16] Some headaches need emergency care. The NHS says to call 999 for a headache that comes on suddenly and is extremely painful, or one with problems speaking, vision loss, drowsiness or confusion, or a seizure.[9]
Treatment
There is no cure, but treatment can manage symptoms and prevent attacks.[5]
For attacks. Short-term options include triptans such as sumatriptan, which act like serotonin in the brain, and over-the-counter pain relievers for less severe attacks.[6] The NHS also lists gepants and anti-sickness medicines.[17] Taking headache medicines too often can backfire. Medication-overuse headache is the most common secondary headache disorder, and the NHS advises trying not to take painkillers on more than 2 days a week.[18]
Prevention. NINDS says people with migraine once a week or more, or with severe but less frequent attacks, are usually offered preventive treatment. Options include anti-seizure medicines, beta-blockers, calcium channel blockers, some antidepressants and, for chronic migraine, botulinum toxin injections.[19] Many supplements sold for migraine have not been thoroughly tested, and some can interact dangerously with medicines.[20]
CGRP drugs. NINDS says eight medicines that block CGRP are available, used either to prevent migraine or to treat attacks.[7] The first, erenumab (Aimovig) from Amgen and Novartis, was approved by the FDA in May 2018 for preventing migraine in adults. It is a monthly self-injection that blocks the CGRP receptor.[8]
Read next: how the immune system works, for background on inflammation and the body’s defences.
Read next
Health in 2026: a crash course
How drugs are tested and approved, who regulates them, and where to start on cholesterol, diabetes, dementia, ALS and cancer screening.
Questions readers ask
How is a migraine different from a normal headache?
Migraine is a health condition that is more than a bad headache. Symptoms often include recurring headaches, nausea, vomiting, mood changes, tiredness and sensitivity to light, noise and smells. The pain is commonly moderate to severe, throbbing and on one side of the head.[1][2]
What is a migraine aura?
Only some people have an aura. It appears about 10 minutes to an hour before the headache and usually lasts no more than an hour. Aura symptoms usually affect vision.[11]
What triggers migraine?
Triggers differ between people. They include weather changes, too much or too little sleep, strong smells, stress, skipped meals, alcohol, hormonal changes and bright or flashing lights.[13]
When is a headache an emergency?
The NHS says to call 999 for a headache that comes on suddenly and is extremely painful, or with problems speaking, vision loss, drowsiness or confusion, or a seizure.[9]
What are CGRP drugs?
CGRP is a protein involved in migraine pain that rises during attacks. NINDS says eight CGRP-blocking medicines are available, used to prevent migraine or to treat attacks. The first, erenumab (Aimovig), was approved by the FDA in May 2018 as a monthly self-injection for prevention.[7][8]
Can taking painkillers too often make headaches worse?
Yes. Medication-overuse headache is the most common secondary headache disorder. The NHS advises trying not to take painkillers on more than 2 days a week.[18]
Sources
· 20 claims from 6 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
Migraine is a health condition that is more than a bad headache: symptoms vary but often include recurring headaches, nausea, vomiting, mood changes, tiredness and sensitivity to light, noise and smells. confirmedas of 2026-11-07
- [2]
A common migraine symptom is moderate to severe throbbing pain, usually on one side of the head. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · What is migraine? (retrieved 2026-11-07)
- [3]
Migraine attacks usually last between 4 hours and 3 days, according to the NHS. confirmedas of 2026-11-07
- Migraine · NHS · Primary source · Symptoms (retrieved 2026-11-07)
- [4]
The WHO says headache disorders affected about 40% of the world's population, 3.1 billion people, in 2021, and migraine ranked third among neurological conditions for disease burden measured in DALYs. confirmedas of 2021-12-31
- Migraine and other headache disorders (fact sheet) · World Health Organization · Primary source · Prevalence (retrieved 2026-11-07)
- Migraine and other headache disorders (fact sheet) · World Health Organization · Primary source · Key facts (retrieved 2026-11-07)
- [5]
There is no cure for migraine, but treatments can help manage symptoms and prevent attacks. confirmedas of 2026-11-07
- [6]
Short-term migraine medicines include triptans such as sumatriptan, which act like serotonin in the brain, ergot derivatives such as ergotamine, CGRP-blocking medicines, and over-the-counter pain relievers for less severe episodes. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Medicines for migraine symptoms (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Medicines for migraine symptoms (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Medicines for migraine symptoms (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Medicines for migraine symptoms (retrieved 2026-11-07)
- [7]
CGRP is a protein involved in migraine pain that rises during attacks; NINDS says eight CGRP-blocking medicines are available, used either to prevent migraine or to treat attacks. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Medicines for migraine symptoms (retrieved 2026-11-07)
- [8]
In May 2018 the FDA approved erenumab (Aimovig), from Amgen and Novartis, as the first CGRP inhibitor for preventing migraine in adults; it is a once-monthly self-injection that blocks the CGRP receptor. confirmedas of 2018-05-17
- FDA Approves Erenumab, First CGRP Inhibitor for Prevention of Migraine · The American Journal of Managed Care (AJMC) · Secondary source · 2018-05-18 · Article, 18 May 2018 (retrieved 2026-11-07)
- FDA Approves Erenumab, First CGRP Inhibitor for Prevention of Migraine · The American Journal of Managed Care (AJMC) · Secondary source · 2018-05-18 · Article, 18 May 2018 (retrieved 2026-11-07)
- First Novel CGRP Inhibitor Gains FDA Approval for Migraine Prevention · NeurologyLive · Secondary source · 2018-05-17 · Article, 17 May 2018 (retrieved 2026-11-07)
- AIMOVIG (erenumab-aooe) prescribing information, initial approval label (BLA 761077) · U.S. Food and Drug Administration · Primary source · Highlights of prescribing information, Indications and usage (Initial U.S. Approval: 2018; Revised: 5/2018) (retrieved 2026-11-14)
- AIMOVIG (erenumab-aooe) prescribing information, initial approval label (BLA 761077) · U.S. Food and Drug Administration · Primary source · Section 2.2, Important Administration Instructions; section 2.1 gives the dosage as once monthly (retrieved 2026-11-14)
- [9]
The NHS says to call 999 for a headache that comes on suddenly and is extremely painful, or with problems speaking, vision loss, confusion, a seizure, one-sided weakness or a recent head injury. confirmedas of 2026-11-07
- [10]
NINDS says current research shows migraine head pain arises when nerve signals, brain chemicals and blood vessels in the brain are not working properly; the WHO says the exact cause is unknown. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · What is migraine? (retrieved 2026-11-07)
- Migraine and other headache disorders (fact sheet) · World Health Organization · Primary source · Migraine (retrieved 2026-11-07)
- [11]
A migraine episode can have a prodrome hours to days before; an aura in some people, usually affecting vision, about 10 minutes to an hour before the headache; the headache phase; and a postdrome, when people are usually exhausted or confused, that can last up to two days. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Phases: prodrome (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Phases: aura (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Phases: postdrome (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Types: migraine with aura (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Phases: postdrome (retrieved 2026-11-07)
- [12]
The most common type is migraine without aura; chronic migraine means migraine headaches on at least 15 days a month for more than three months. confirmedas of 2026-11-07
- [13]
Migraine triggers differ between people and include weather changes, too much or too little sleep, strong smells, stress, skipped meals, alcohol, hormonal changes and bright or flashing lights. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Triggers (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Triggers (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Triggers (retrieved 2026-11-07)
- [14]
Hormonal changes are likely why females experience migraine more than males, and most females see improvement after menopause. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Who is more likely to have migraine? (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Who is more likely to have migraine? (retrieved 2026-11-07)
- [15]
People with migraine more commonly have depression, anxiety and sleep disorders; WHO says anxiety and depression are significantly more common in people who have migraine. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Who is more likely to have migraine? (retrieved 2026-11-07)
- Migraine and other headache disorders (fact sheet) · World Health Organization · Primary source · Prevalence (retrieved 2026-11-07)
- [16]
Migraine is diagnosed from health history and physical and neurological exams; MRI or CT scans are not usually used unless another condition is suspected, and a headache journal can help. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Diagnosing migraine (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Keeping a headache journal (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Diagnosing migraine (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Diagnosing migraine (retrieved 2026-11-07)
- [17]
The NHS lists painkillers, triptans and gepants, and anti-sickness medicines as treatments for migraine attacks, and beta blockers, antidepressants and epilepsy medicines among preventive options. confirmedas of 2026-11-07
- [18]
Medication-overuse headache, caused by frequent use of headache medicines, is the most common secondary headache disorder; the NHS advises trying not to take painkillers on more than 2 days a week. confirmedas of 2026-11-07
- Migraine and other headache disorders (fact sheet) · World Health Organization · Primary source · Medication-overuse headache (retrieved 2026-11-07)
- Migraine · NHS · Primary source · Treatment (retrieved 2026-11-07)
- [19]
NINDS says people with migraine once a week or more, or with severe but less frequent episodes, are usually prescribed preventive treatment, which can include anticonvulsants, beta-blockers, calcium channel blockers, some antidepressants and, for chronic migraine, botulinum toxin. confirmedas of 2026-11-07
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Preventive medicines (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Preventive medicines (retrieved 2026-11-07)
- Migraine · National Institute of Neurological Disorders and Stroke (NIH) · Primary source · Preventive medicines (retrieved 2026-11-07)
- [20]
Many dietary supplements marketed for migraine have not been thoroughly tested, and some can interact dangerously with medicines. confirmedas of 2026-11-07
Revision history (2)
- Added the FDA prescribing information as a primary source for the 2018 erenumab approval.
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: May 7, 2027.
Cite this page
"Migraine explained: symptoms, triggers and the CGRP drugs." ContentLora, updated Nov 14, 2026. https://contentlora.com/explain/migraine-explained
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.